annual EBITDA:
-$3.76B-$473.00M(-14.41%)Summary
- As of today (May 21, 2025), MRNA annual EBITDA is -$3.76 billion, with the most recent change of -$473.00 million (-14.41%) on December 31, 2024.
- During the last 3 years, MRNA annual EBITDA has fallen by -$17.28 billion (-127.76%).
- MRNA annual EBITDA is now -127.76% below its all-time high of $13.53 billion, reached on December 31, 2021.
Performance
MRNA EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$924.00M+$194.00M(+17.35%)Summary
- As of today (May 21, 2025), MRNA quarterly EBITDA is -$924.00 million, with the most recent change of +$194.00 million (+17.35%) on March 31, 2025.
- Over the past year, MRNA quarterly EBITDA has increased by +$199.00 million (+17.72%).
- MRNA quarterly EBITDA is now -116.84% below its all-time high of $5.49 billion, reached on December 31, 2021.
Performance
MRNA quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$3.19B+$199.00M(+5.86%)Summary
- As of today (May 21, 2025), MRNA TTM EBITDA is -$3.19 billion, with the most recent change of +$199.00 million (+5.86%) on March 31, 2025.
- Over the past year, MRNA TTM EBITDA has increased by +$993.00 million (+23.71%).
- MRNA TTM EBITDA is now -119.29% below its all-time high of $16.56 billion, reached on March 31, 2022.
Performance
MRNA TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
MRNA EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -14.4% | +17.7% | +23.7% |
| 3 y3 years | -127.8% | -121.4% | -119.3% |
| 5 y5 years | -629.3% | -696.5% | -529.9% |
MRNA EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -127.8% | at low | -121.4% | +45.6% | -119.3% | +23.7% |
| 5 y | 5-year | -127.8% | at low | -116.8% | +45.6% | -119.3% | +23.7% |
| alltime | all time | -127.8% | at low | -116.8% | +45.6% | -119.3% | +23.7% |
MRNA EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$924.00M(-17.4%) | -$3.19B(-5.9%) |
| Dec 2024 | -$3.76B(+14.4%) | -$1.12B(-1515.2%) | -$3.39B(+69.9%) |
| Sep 2024 | - | $79.00M(-106.4%) | -$2.00B(-47.1%) |
| Jun 2024 | - | -$1.23B(+9.7%) | -$3.78B(-9.8%) |
| Mar 2024 | - | -$1.12B(-504.0%) | -$4.19B(+27.6%) |
| Dec 2023 | -$3.28B(-133.0%) | $278.00M(-116.4%) | -$3.28B(+64.1%) |
| Sep 2023 | - | -$1.70B(+3.3%) | -$2.00B(-292.9%) |
| Jun 2023 | - | -$1.64B(+654.1%) | $1.04B(-80.2%) |
| Mar 2023 | - | -$218.00M(-114.0%) | $5.24B(-46.4%) |
| Dec 2022 | $9.95B(-26.4%) | $1.56B(+16.7%) | $9.77B(-28.7%) |
| Sep 2022 | - | $1.34B(-47.6%) | $13.69B(-14.3%) |
| Jun 2022 | - | $2.56B(-40.8%) | $15.98B(-3.5%) |
| Mar 2022 | - | $4.31B(-21.4%) | $16.56B(+22.4%) |
| Dec 2021 | $13.53B(-1948.1%) | $5.49B(+51.3%) | $13.53B(+74.5%) |
| Sep 2021 | - | $3.63B(+15.6%) | $7.75B(+98.5%) |
| Jun 2021 | - | $3.14B(+145.5%) | $3.90B(+489.9%) |
| Mar 2021 | - | $1.28B(-542.2%) | $662.00M(-190.4%) |
| Dec 2020 | -$732.00M(+42.1%) | -$289.00M(+30.8%) | -$732.00M(+23.3%) |
| Sep 2020 | - | -$221.00M(+108.5%) | -$593.74M(+21.9%) |
| Jun 2020 | - | -$106.00M(-8.6%) | -$487.23M(-3.9%) |
| Mar 2020 | - | -$116.00M(-23.0%) | -$507.25M(-1.5%) |
| Dec 2019 | -$515.00M(+44.5%) | -$150.74M(+31.7%) | -$515.00M(+3.7%) |
| Sep 2019 | - | -$114.48M(-9.2%) | -$496.64M(+9.3%) |
| Jun 2019 | - | -$126.02M(+1.8%) | -$454.49M(+10.0%) |
| Mar 2019 | - | -$123.75M(-6.5%) | -$413.00M(+15.9%) |
| Dec 2018 | -$356.45M(+51.5%) | -$132.38M(+83.0%) | -$356.45M(+44.6%) |
| Sep 2018 | - | -$72.33M(-14.4%) | -$246.49M(+40.9%) |
| Jun 2018 | - | -$84.54M(+25.8%) | -$174.98M(+91.3%) |
| Mar 2018 | - | -$67.20M(+199.7%) | -$91.49M(+262.1%) |
| Dec 2017 | -$235.33M(+12.8%) | -$22.42M(+2618.4%) | -$25.27M(+668.2%) |
| Sep 2017 | - | -$824.80K(-21.4%) | -$3.29M(+28.4%) |
| Jun 2017 | - | -$1.05M(+8.0%) | -$2.56M(+56.1%) |
| Mar 2017 | - | -$971.90K(+119.2%) | -$1.64M(+109.5%) |
| Dec 2016 | -$208.66M(-6351.0%) | - | - |
| Dec 2016 | - | -$443.30K(+353.7%) | -$783.60K(-112.3%) |
| Sep 2016 | - | -$97.70K(-23.9%) | $6.37M(+17.2%) |
| Jun 2016 | - | -$128.40K(+12.4%) | $5.43M(+19.7%) |
| Mar 2016 | - | -$114.20K(-101.7%) | $4.54M(+36.0%) |
| Dec 2015 | $3.34M(-161.0%) | $6.71M(-749.9%) | $3.34M(+37.2%) |
| Sep 2015 | - | -$1.03M(+1.0%) | $2.43M(-166.5%) |
| Jun 2015 | - | -$1.02M(-22.3%) | -$3.66M(-384.7%) |
| Mar 2015 | - | -$1.31M(-122.7%) | $1.28M(-123.5%) |
| Dec 2014 | -$5.47M(+302.0%) | $5.80M(-181.5%) | -$5.47M(-58.6%) |
| Sep 2014 | - | -$7.12M(-281.7%) | -$13.21M(+88.7%) |
| Jun 2014 | - | $3.92M(-148.6%) | -$7.00M(-37.0%) |
| Mar 2014 | - | -$8.07M(+316.0%) | -$11.11M(+593.0%) |
| Dec 2013 | -$1.36M(-81.2%) | -$1.94M(+112.7%) | -$1.60M(-63.8%) |
| Sep 2013 | - | -$912.00K(+390.3%) | -$4.43M(-9.7%) |
| Jun 2013 | - | -$186.00K(-113.0%) | -$4.90M(+131.4%) |
| Mar 2013 | - | $1.44M(-130.1%) | -$2.12M(-70.7%) |
| Dec 2012 | -$7.24M(-73.2%) | -$4.76M(+242.9%) | -$7.24M(-61.7%) |
| Sep 2012 | - | -$1.39M(-153.5%) | -$18.87M(-12.5%) |
| Jun 2012 | - | $2.60M(-170.6%) | -$21.57M(-26.2%) |
| Mar 2012 | - | -$3.68M(-77.5%) | -$29.21M(-3.3%) |
| Dec 2011 | -$27.03M(+15.8%) | -$16.40M(+301.3%) | -$30.21M(+66.8%) |
| Sep 2011 | - | -$4.09M(-19.1%) | -$18.11M(-16.3%) |
| Jun 2011 | - | -$5.05M(+7.9%) | -$21.63M(+9.5%) |
| Mar 2011 | - | -$4.68M(+8.7%) | -$19.75M(-4.2%) |
| Dec 2010 | -$23.35M(+196.7%) | -$4.30M(-43.4%) | -$20.61M(+7.8%) |
| Sep 2010 | - | -$7.61M(+140.2%) | -$19.12M(+6.4%) |
| Jun 2010 | - | -$3.17M(-42.8%) | -$17.96M(-16.6%) |
| Mar 2010 | - | -$5.54M(+97.2%) | -$21.55M(+192.6%) |
| Dec 2009 | -$7.87M | -$2.81M(-56.5%) | -$7.37M(-53.6%) |
| Sep 2009 | - | -$6.45M(-4.4%) | -$15.87M(-12.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2009 | - | -$6.75M(-178.1%) | -$18.18M(-25.6%) |
| Mar 2009 | - | $8.65M(-176.5%) | -$24.44M(-47.5%) |
| Dec 2008 | -$46.57M(-7.1%) | -$11.31M(+29.0%) | -$46.57M(+0.3%) |
| Sep 2008 | - | -$8.77M(-32.6%) | -$46.42M(-13.2%) |
| Jun 2008 | - | -$13.01M(-3.5%) | -$53.48M(+2.1%) |
| Mar 2008 | - | -$13.48M(+20.8%) | -$52.40M(+4.5%) |
| Dec 2007 | -$50.14M(+89.8%) | -$11.16M(-29.4%) | -$50.14M(+2.1%) |
| Sep 2007 | - | -$15.82M(+32.5%) | -$49.13M(+19.9%) |
| Jun 2007 | - | -$11.94M(+6.4%) | -$40.96M(+38.6%) |
| Mar 2007 | - | -$11.22M(+10.5%) | -$29.55M(+11.9%) |
| Dec 2006 | -$26.41M(-17.4%) | -$10.15M(+32.7%) | -$26.41M(+4.8%) |
| Sep 2006 | - | -$7.65M(+1354.6%) | -$25.20M(-4.3%) |
| Jun 2006 | - | -$526.00K(-93.5%) | -$26.33M(-22.7%) |
| Mar 2006 | - | -$8.09M(-9.6%) | -$34.06M(+6.6%) |
| Dec 2005 | -$31.97M(+18.2%) | -$8.94M(+1.8%) | -$31.97M(+11.8%) |
| Sep 2005 | - | -$8.78M(+6.3%) | -$28.59M(+6.0%) |
| Jun 2005 | - | -$8.26M(+37.8%) | -$26.98M(+4.9%) |
| Mar 2005 | - | -$5.99M(+7.7%) | -$25.71M(-4.9%) |
| Dec 2004 | -$27.05M(+463.9%) | -$5.56M(-22.4%) | -$27.05M(-0.5%) |
| Sep 2004 | - | -$7.17M(+2.5%) | -$27.19M(+4.6%) |
| Jun 2004 | - | -$6.99M(-4.5%) | -$25.99M(+166.3%) |
| Mar 2004 | - | -$7.32M(+28.5%) | -$9.76M(+103.5%) |
| Dec 2003 | -$4.80M(-58.6%) | -$5.70M(-4.7%) | -$4.80M(+30.6%) |
| Sep 2003 | - | -$5.98M(-164.7%) | -$3.67M(+356.7%) |
| Jun 2003 | - | $9.24M(-491.6%) | -$804.00K(-92.9%) |
| Mar 2003 | - | -$2.36M(-48.4%) | -$11.26M(-2.8%) |
| Dec 2002 | -$11.59M(+33.1%) | -$4.57M(+47.1%) | -$11.59M(+17.1%) |
| Sep 2002 | - | -$3.11M(+155.3%) | -$9.89M(+16.9%) |
| Jun 2002 | - | -$1.22M(-54.7%) | -$8.46M(-8.0%) |
| Mar 2002 | - | -$2.69M(-6.8%) | -$9.20M(+5.7%) |
| Dec 2001 | -$8.71M(-9.3%) | -$2.88M(+71.5%) | -$8.71M(-6.8%) |
| Sep 2001 | - | -$1.68M(-13.9%) | -$9.34M(+0.3%) |
| Jun 2001 | - | -$1.95M(-10.9%) | -$9.31M(-2.9%) |
| Mar 2001 | - | -$2.19M(-37.7%) | -$9.60M(-0.1%) |
| Dec 2000 | -$9.60M(+6.1%) | -$3.52M(+112.8%) | -$9.60M(-3.4%) |
| Sep 2000 | - | -$1.65M(-26.0%) | -$9.94M(-2.1%) |
| Jun 2000 | - | -$2.23M(+1.6%) | -$10.15M(+6.7%) |
| Mar 2000 | - | -$2.20M(-43.0%) | -$9.51M(-1.1%) |
| Dec 1999 | -$9.05M(+341.2%) | -$3.85M(+106.9%) | -$9.62M(+18.5%) |
| Sep 1999 | - | -$1.86M(+16.4%) | -$8.11M(+25.8%) |
| Jun 1999 | - | -$1.60M(-30.4%) | -$6.45M(+27.7%) |
| Mar 1999 | - | -$2.30M(-2.2%) | -$5.05M(+77.1%) |
| Dec 1998 | -$2.05M(-64.0%) | -$2.35M(+1076.0%) | -$2.85M(+1.9%) |
| Sep 1998 | - | -$200.00K(0.0%) | -$2.80M(-33.3%) |
| Jun 1998 | - | -$200.00K(+100.0%) | -$4.20M(-20.8%) |
| Mar 1998 | - | -$100.00K(-95.7%) | -$5.30M(-10.2%) |
| Dec 1997 | -$5.70M(+1040.0%) | -$2.30M(+43.8%) | -$5.90M(+63.9%) |
| Sep 1997 | - | -$1.60M(+23.1%) | -$3.60M(+80.0%) |
| Jun 1997 | - | -$1.30M(+85.7%) | -$2.00M(+300.0%) |
| Mar 1997 | - | -$700.00K(<-9900.0%) | -$500.00K(<-9900.0%) |
| Dec 1996 | -$500.00K(<-9900.0%) | - | - |
| Sep 1996 | - | $0.00(-100.0%) | $0.00(-100.0%) |
| Jun 1996 | $0.00(-100.0%) | $200.00K(+100.0%) | -$100.00K(-66.7%) |
| Mar 1996 | - | $100.00K(-133.3%) | -$300.00K(-25.0%) |
| Dec 1995 | - | -$300.00K(+200.0%) | -$400.00K(+100.0%) |
| Sep 1995 | - | -$100.00K(<-9900.0%) | -$200.00K(<-9900.0%) |
| Jun 1995 | -$100.00K(-150.0%) | $0.00(0.0%) | $0.00(-100.0%) |
| Mar 1995 | - | $0.00(-100.0%) | $100.00K(>+9900.0%) |
| Dec 1994 | - | -$100.00K(-200.0%) | $0.00(-100.0%) |
| Sep 1994 | - | $100.00K(0.0%) | $200.00K(0.0%) |
| Jun 1994 | $200.00K | $100.00K(-200.0%) | $200.00K(+100.0%) |
| Mar 1994 | - | -$100.00K(-200.0%) | $100.00K(-50.0%) |
| Dec 1993 | - | $100.00K(0.0%) | $200.00K(+100.0%) |
| Sep 1993 | - | $100.00K | $100.00K |
FAQ
- What is Moderna annual EBITDA?
- What is the all time high annual EBITDA for Moderna?
- What is Moderna annual EBITDA year-on-year change?
- What is Moderna quarterly EBITDA?
- What is the all time high quarterly EBITDA for Moderna?
- What is Moderna quarterly EBITDA year-on-year change?
- What is Moderna TTM EBITDA?
- What is the all time high TTM EBITDA for Moderna?
- What is Moderna TTM EBITDA year-on-year change?
What is Moderna annual EBITDA?
The current annual EBITDA of MRNA is -$3.76B
What is the all time high annual EBITDA for Moderna?
Moderna all-time high annual EBITDA is $13.53B
What is Moderna annual EBITDA year-on-year change?
Over the past year, MRNA annual EBITDA has changed by -$473.00M (-14.41%)
What is Moderna quarterly EBITDA?
The current quarterly EBITDA of MRNA is -$924.00M
What is the all time high quarterly EBITDA for Moderna?
Moderna all-time high quarterly EBITDA is $5.49B
What is Moderna quarterly EBITDA year-on-year change?
Over the past year, MRNA quarterly EBITDA has changed by +$199.00M (+17.72%)
What is Moderna TTM EBITDA?
The current TTM EBITDA of MRNA is -$3.19B
What is the all time high TTM EBITDA for Moderna?
Moderna all-time high TTM EBITDA is $16.56B
What is Moderna TTM EBITDA year-on-year change?
Over the past year, MRNA TTM EBITDA has changed by +$993.00M (+23.71%)